Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Will Buffet, Bezos, and Dimon be able to control health care costs?

Peter F. Nichol, MD, PhD
Policy
February 17, 2018
Share
Tweet
Share

The recent announcement that Berkshire Hathaway, Amazon, and JPMorgan have joined forces to pare down health care costs has sent ripple effects across the health care space. The announcement sent stocks tumbling due to the uncertainty of what influence these companies will have on a deeply complex, unruly and wasteful health care system.

Said Berkshire Hathaway chair and CEO Warren Buffett: “The ballooning costs of health care act as a hungry tapeworm on the American economy, our group does not come to this problem with answers. But we also do not accept it as inevitable.”

Mr. Buffet is correct on all counts of course. But where these three companies are willing to go to fix this massive problem is really the question. The Wall Street Journal astutely pointed this out: “There were almost no details available about what the company would do or how it would use technology to disrupt and simplify the complicated fabric of American health care.” They also quoted an unnamed source as saying: “That the joint venture is not currently expected to be a new health insurance company or a hospital or a pharmaceutical company, but a company that can bring technology tools to bear on making health care more transparent, affordable and simple.” So as opposed to Henry Ford who got so fed up with this exact problem 100+ years ago that he built an altogether new type of hospital, we are not hearing any new ideas from these three companies.

Health care accounts for almost a fifth of our economy, but standing on the sidelines urging new and established tech companies to disrupt the market is about as strategic as throwing socks at the wall and hoping they will stick.

In fact, aside from controlling costs, there is little of standard business economics that applies in this space. Health care economics is not about selling widgets and mergers and acquisitions do not control costs via economies of scale. Rather it is about nurturing and growing community wealth and health by looking at every variable in an environment and understanding how it affects the health of your community. This includes chemical pollution of our water supply, greenhouse gases, particulate air pollution, personal bankruptcy, the quality of food in the food chain, prenatal care, early childhood education and a litany of other variables that are not purchased at the corner pharmacy or from a medical device manufacturer.

To be sure, looking inward to reduce waste in the system is a great place to start. By some estimates, this will remove $600 to $800 billion of cost. That still leaves us with an annual bill of about $2.5 trillion. But this approach will not change the soaring rates of diabetes, heart disease, obesity, mental illness, Alzheimer’s and other diseases that account for such a large portion of health care dollars.

If these three titans of business really want to transform health care, then they need to use their economic heft and bully pulpit to evolve the discussion from controlling costs to one of maximizing value and improving health. They will need to make a nation see that almost everything within our environment affects our health and contributes to the rising costs of taking care of an increasingly unhealthy population. Changing that dialogue doesn’t require them to start a new company or throw money at the problem, but it will require courage and perseverance in order to tame a deeply complex, unruly and wasteful health care system.

Peter F. Nichol is chief medical officer, Medaware Systems.

Image credit: Shutterstock.com

Prev

The devaluation of physicians' time must end

February 17, 2018 Kevin 47
…
Next

After retirement: How should this physician handle money?

February 18, 2018 Kevin 0
…

Tagged as: Public Health & Policy

Post navigation

< Previous Post
The devaluation of physicians' time must end
Next Post >
After retirement: How should this physician handle money?

ADVERTISEMENT

More by Peter F. Nichol, MD, PhD

  • Rethinking consent in the age of Facebook and Cambridge Analytica

    Peter F. Nichol, MD, PhD
  • A better way of using Lyft and Uber in health care

    Peter F. Nichol, MD, PhD
  • If academic medicine is to avoid becoming academic, it must prioritize patient care

    Peter F. Nichol, MD, PhD

Related Posts

  • How social media can help or hurt your health care career

    Health eCareers
  • America leads the world in high tech care and health care costs

    Mark Kelley, MD
  • Turn physicians into powerful health care influencers

    Kevin Pho, MD
  • Why should health care professionals care about gun control?

    Sobia Ansari, MD, MPH
  • How inflation fueled health care costs

    Ricardo Chujutalli, MD, MBA and Jessica Yoong
  • 3 reasons why health care costs are rising

    Samuel Falkson

More in Policy

  • Online eye exams spark legal battle over health care access

    Joshua Windham, JD and Daryl James
  • The One Big Beautiful Bill and the fragile heart of rural health care

    Holland Haynie, MD
  • Why health care leaders fail at execution—and how to fix it

    Dave Cummings, RN
  • Healing the doctor-patient relationship by attacking administrative inefficiencies

    Allen Fredrickson
  • The hidden health risks in the One Big Beautiful Bill Act

    Trevor Lyford, MPH
  • The CDC’s restructuring: Where is the voice of health care in the room?

    Tarek Khrisat, MD
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI is already replacing doctors—just not how you think

      Bhargav Raman, MD, MBA | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 13 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI is already replacing doctors—just not how you think

      Bhargav Raman, MD, MBA | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Will Buffet, Bezos, and Dimon be able to control health care costs?
13 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...